The weekly litigation news digest is live. Subscribe now

Vaccine For Pcv2 And Mycoplasma - EP2994162

The patent EP2994162 was granted to Pharmgate Biologics on Apr 7, 2021. The application was originally filed on May 8, 2014 under application number EP14794866A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2994162

PHARMGATE BIOLOGICS
Application Number
EP14794866A
Filing Date
May 8, 2014
Status
Granted And Under Opposition
Mar 5, 2021
Publication Date
Apr 7, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOEHRINGER INGELHEIM VETMEDICAJan 7, 2022HOFFMANN EITLEADMISSIBLE

Patent Citations (20) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS8008001
DESCRIPTIONUS8119143
INTERNATIONAL-SEARCH-REPORTUS2003092897
INTERNATIONAL-SEARCH-REPORTUS2009092636
INTERNATIONAL-SEARCH-REPORTUS2009317423
INTERNATIONAL-SEARCH-REPORTUS2010062018
INTERNATIONAL-SEARCH-REPORTUS2011129494
OPPOSITIONEP0571648
OPPOSITIONUS2003092897
OPPOSITIONUS2004223982
OPPOSITIONUS2009317423
OPPOSITIONUS2011129494
OPPOSITIONWO2010044889
OPPOSITIONWO2011031850
OPPOSITIONWO2013152083
OPPOSITIONWO2013152086
OPPOSITIONWO2014182872
SEARCHUS5733555
SEARCHWO03005952
SEARCHWO9517210

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents